Related Experiment Video

Updated: Aug 6, 2026

Mass Production of Genetically Modified Aedes aegypti for Field Releases in Brazil
17:41

Mass Production of Genetically Modified Aedes aegypti for Field Releases in Brazil

Published on: January 4, 2014

[Aedes aegypti resistance to temefos in counties of Ceará State]

Estelita Pereira Lima1, Alfredo Martins de Oliveira Filho, José Wellington de Oliveira Lima

  • 1Departamento de Saúde Comunitária, Universidade Federal do Ceará, Rua Prof. Costa Mendes 1608/5o andar, Rodolfo Teófilo, 60430-140 Fortaleza, CE.

Revista Da Sociedade Brasileira De Medicina Tropical
|August 15, 2006
PubMed

More Related Videos

Topical Application Bioassay to Quantify Insecticide Toxicity for Mosquitoes and Fruit Flies09:37

Topical Application Bioassay to Quantify Insecticide Toxicity for Mosquitoes and Fruit Flies

Published on: January 19, 2022

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...